Chongqing Zhifei Biological Products Co Ltd
SZSE:300122

Watchlist Manager
Chongqing Zhifei Biological Products Co Ltd Logo
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Watchlist
Price: 30.88 CNY -5.07% Market Closed
Market Cap: 74.1B CNY
Have any thoughts about
Chongqing Zhifei Biological Products Co Ltd?
Write Note

Chongqing Zhifei Biological Products Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chongqing Zhifei Biological Products Co Ltd
Net Income (Common) Peer Comparison

Comparables:
6160
1801
603392
002252
300896

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Net Income (Common)
ÂĄ6B
CAGR 3-Years
-6%
CAGR 5-Years
26%
CAGR 10-Years
48%
Beigene Ltd
HKEX:6160
Net Income (Common)
-ÂĄ6.7B
CAGR 3-Years
16%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Net Income (Common)
-ÂĄ1.3B
CAGR 3-Years
3%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Net Income (Common)
ÂĄ1.2B
CAGR 3-Years
23%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Net Income (Common)
ÂĄ1.8B
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
23%
Imeik Technology Development Co Ltd
SZSE:300896
Net Income (Common)
ÂĄ1.9B
CAGR 3-Years
62%
CAGR 5-Years
72%
CAGR 10-Years
N/A

See Also

What is Chongqing Zhifei Biological Products Co Ltd's Net Income (Common)?
Net Income (Common)
6B CNY

Based on the financial report for Jun 30, 2024, Chongqing Zhifei Biological Products Co Ltd's Net Income (Common) amounts to 6B CNY.

What is Chongqing Zhifei Biological Products Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
48%

Over the last year, the Net Income (Common) growth was -25%. The average annual Net Income (Common) growth rates for Chongqing Zhifei Biological Products Co Ltd have been -6% over the past three years , 26% over the past five years , and 48% over the past ten years .

Back to Top